CS
Cove Street Capital, LLC
13F filer · CIK 0001531612Last filed Nov 13, 2025
Inactive · not filing 13F
13F portfolio value$76.6MU.S. long equity reported on 13F
Positions855 new · 8 closed
Net flow last quarter-$5.7MBuys minus sells
Top 10 positions weight47.1%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q3 2025Reported Nov 13, 202585 positions | |||||
| $8.03M | 10.49% | 4.92% | +12.1% | Q2 2014 | |
| $4.98M | 6.51% | 4.07% | -0.1% | Q4 2020 | |
| $4.64M | 6.07% | 0.20% | +1711.4% | Q3 2024 | |
| $3.48M | 4.55% | 0.09% | -54.0% | Q2 2014 | |
| $2.75M | 3.59% | 0.28% | -44.9% | Q3 2021 | |
| $2.63M | 3.44% | 0.02% | +1.3% | Q3 2020 | |
| $2.6M | 3.39% | 0.33% | +59.9% | Q1 2025 | |
| $2.54M | 3.32% | 0.41% | +20.7% | Q1 2021 | |
| $2.27M | 2.97% | 0.06% | -1.6% | Q3 2024 | |
| $2.14M | 2.79% | 0.03% | +2.4% | Q3 2017 | |
| $2.07M | 2.70% | 0.07% | +1.6% | Q3 2016 | |
| $2.02M | 2.64% | 0.04% | -0.1% | Q1 2025 | |
| $1.95M | 2.55% | Not reported | +3.2% | Q4 2024 | |
| $1.92M | 2.50% | Not reported | +20.3% | Q1 2022 | |
| $1.81M | 2.36% | 0.04% | +128.5% | Q2 2013 | |
| $1.73M | 2.26% | 0.07% | +4075.2% | Q3 2024 | |
| $1.59M | 2.08% | 0.00% | -6.3% | Q1 2022 | |
| $1.49M | 1.95% | 0.58% | +57.5% | Q4 2019 | |
| $1.47M | 1.92% | 0.00% | -1.6% | Q1 2023 | |
| $1.45M | 1.90% | 0.02% | -0.2% | Q1 2024 | |
| $1.44M | 1.88% | 0.00% | -0.8% | Q2 2013 | |
| $1.37M | 1.79% | 0.17% | -0.2% | Q4 2016 | |
| $1.35M | 1.76% | 0.08% | Not reported | Q2 2022 | |
| $1.33M | 1.74% | 0.00% | -64.7% | Q1 2022 | |
| AMAVNSAvanos Medical, Inc. | $1.3M | 1.69% | 0.24% | +430.7% | Q4 2019 |
| $1.18M | 1.54% | 0.00% | Not reported | Q3 2017 | |
| $1.15M | 1.50% | Not reported | Not reported | Q1 2020 | |
| $958K | 1.25% | 0.71% | +37.6% | Q4 2014 | |
| $877K | 1.15% | Not reported | -43.6% | Q4 2014 | |
| $677K | 0.88% | 1.07% | +2.7% | Q2 2025 | |
| $649K | 0.85% | 0.00% | -12.2% | Q4 2024 | |
| $545K | 0.71% | Not reported | +5.6% | Q1 2018 | |
| $417K | 0.54% | 0.14% | +911.0% | Q2 2025 | |
| $396K | 0.52% | 0.00% | Not reported | Q3 2024 | |
| $383K | 0.50% | 0.05% | -7.0% | Q1 2024 | |
| $376K | 0.49% | 0.09% | -14.4% | Q4 2019 | |
| $365K | 0.48% | 0.00% | Not reported | Q3 2024 | |
| $365K | 0.48% | Not reported | Not reported | Q1 2024 | |
| $311K | 0.41% | 0.00% | Not reported | Q3 2024 | |
| $306K | 0.40% | 0.00% | Not reported | Q3 2024 | |
| $303K | 0.40% | 0.08% | +46.3% | Q2 2013 | |
| $233K | 0.30% | 0.00% | Not reported | Q3 2024 | |
| $207K | 0.27% | 0.02% | +50.9% | Q1 2023 | |
| $193K | 0.25% | 0.00% | Not reported | Q3 2024 | |
| $185K | 0.24% | 0.00% | Not reported | Q3 2017 | |
| $180K | 0.24% | 0.00% | -39.9% | Q2 2025 | |
| $165K | 0.22% | 0.00% | Not reported | Q3 2024 | |
| $124K | 0.16% | 0.00% | Not reported | Q2 2013 | |
| $121K | 0.16% | 0.00% | Not reported | Q3 2024 | |
| $115K | 0.15% | 0.00% | Not reported | Q3 2024 | |
| Q2 2025Reported Aug 14, 202588 positions | |||||
| $4.89M | 7.18% | 4.40% | +11.5% | Q2 2014 | |
| $4.69M | 6.88% | 0.50% | -10.7% | Q3 2021 | |
| $3.84M | 5.63% | 4.12% | -0.6% | Q4 2020 | |
| $3.78M | 5.54% | 0.20% | +31.1% | Q2 2014 | |
| $2.35M | 3.44% | 0.05% | -3.4% | Q3 2020 | |
| $2.21M | 3.24% | 0.01% | -26.2% | Q1 2022 | |
| $1.89M | 2.77% | 0.04% | +17.3% | Q1 2025 | |
| $1.87M | 2.74% | Not reported | -10.5% | Q4 2014 | |
| $1.81M | 2.66% | 0.07% | +504790.9% | Q3 2016 | |
| $1.76M | 2.58% | 0.00% | Not reported | Q1 2022 | |
| $1.75M | 2.56% | 0.06% | -30.9% | Q3 2024 | |
| $1.75M | 2.56% | Not reported | -34.5% | Q1 2022 | |
| $1.74M | 2.56% | 0.03% | -1.1% | Q3 2017 | |
| $1.67M | 2.45% | 0.34% | +90.3% | Q1 2021 | |
| $1.6M | 2.35% | Not reported | +24525.3% | Q4 2024 | |
| $1.55M | 2.28% | Not reported | Not reported | Q1 2024 | |
| $1.49M | 2.18% | 0.03% | -0.8% | Q3 2015 | |
| $1.45M | 2.13% | 1.14% | +10.5% | Q2 2022 | |
| $1.44M | 2.11% | 0.17% | -47.0% | Q4 2016 | |
| $1.43M | 2.10% | 0.00% | Not reported | Q1 2023 | |
| $1.39M | 2.04% | 0.08% | +33.2% | Q2 2022 | |
| $1.22M | 1.78% | 0.00% | Not reported | Q2 2013 | |
| $1.2M | 1.76% | 0.21% | +24685.6% | Q1 2025 | |
| $1.18M | 1.73% | 0.02% | -28.7% | Q1 2024 | |
| $1.12M | 1.65% | 0.00% | Not reported | Q3 2017 | |
| $1.11M | 1.63% | Not reported | -23.8% | Q1 2020 | |
| $965K | 1.42% | 0.35% | -1.4% | Q4 2019 | |
| $929K | 1.36% | 0.70% | -0.9% | Q3 2024 | |
| $851K | 1.25% | 0.02% | -3.5% | Q2 2013 | |
| $784K | 1.15% | 0.51% | -1.1% | Q4 2014 | |
| $659K | 0.97% | 0.00% | Not reported | Q4 2024 | |
| $573K | 0.84% | 0.06% | -66.7% | Q2 2021 | |
| $561K | 0.82% | 0.00% | Not reported | Q2 2013 | |
| $557K | 0.82% | Not reported | -49.9% | Q1 2018 | |
| $521K | 0.76% | 0.03% | -1.3% | Q4 2021 | |
| $446K | 0.65% | 1.05% | New | Q2 2025 | |
| $388K | 0.57% | 0.06% | -5.0% | Q1 2024 | |
| $361K | 0.53% | Not reported | Not reported | Q1 2024 | |
| $343K | 0.50% | 0.01% | -3.2% | Q3 2024 | |
| $331K | 0.49% | 0.00% | Not reported | Q3 2024 | |
| $319K | 0.47% | 0.11% | -4.8% | Q4 2019 | |
| $298K | 0.44% | 0.00% | Not reported | Q3 2024 | |
| $281K | 0.41% | 0.00% | New | Q2 2025 | |
| $278K | 0.41% | 0.00% | Not reported | Q3 2020 | |
| $264K | 0.39% | 0.00% | Not reported | Q3 2024 | |
| AMAVNSAvanos Medical, Inc. | $258K | 0.38% | 0.05% | -4.9% | Q4 2019 |
| $246K | 0.36% | 0.00% | Not reported | Q3 2024 | |
| $233K | 0.34% | 0.00% | Not reported | Q3 2024 | |
| $209K | 0.31% | 0.00% | Not reported | Q3 2024 | |
| $205K | 0.30% | 0.05% | -5.4% | Q2 2013 | |
| Q1 2025Reported May 15, 202589 positions | |||||
| $4.93M | 7.74% | 3.96% | +35.0% | Q2 2014 | |
| $3.96M | 6.21% | 0.54% | +29.8% | Q3 2021 | |
| $3.5M | 5.49% | 4.15% | -23.8% | Q4 2020 | |
| $3.28M | 5.15% | Not reported | -11.3% | Q1 2022 | |
| $2.8M | 4.39% | 0.01% | -28.9% | Q1 2022 | |
| $2.13M | 3.35% | 0.09% | -30.1% | Q3 2024 | |
| $2.09M | 3.28% | Not reported | -44.2% | Q4 2014 | |
| $2.06M | 3.23% | 0.15% | -27.8% | Q2 2014 | |
| $2.04M | 3.20% | 0.05% | -10.7% | Q3 2020 | |
| $1.76M | 2.76% | 0.19% | -12.9% | Q2 2021 | |
| $1.72M | 2.70% | 0.03% | New | Q1 2025 | |
| $1.71M | 2.69% | 0.00% | -42.7% | Q1 2022 | |
| $1.59M | 2.50% | Not reported | -23.9% | Q1 2020 | |
| $1.51M | 2.38% | 0.03% | +38.8% | Q3 2015 | |
| $1.44M | 2.27% | 0.03% | -27.8% | Q3 2017 | |
| $1.36M | 2.13% | 0.05% | -52.3% | Q3 2024 | |
| $1.34M | 2.10% | 0.03% | -9.5% | Q1 2024 | |
| $1.28M | 2.00% | 0.06% | -22.2% | Q2 2022 | |
| $1.25M | 1.97% | 0.33% | -33.0% | Q4 2016 | |
| $1.23M | 1.93% | 0.00% | -47.5% | Q1 2023 | |
| $1.22M | 1.92% | Not reported | -20.5% | Q1 2018 | |
| $1.13M | 1.78% | 1.00% | +8.7% | Q2 2022 | |
| $1.13M | 1.77% | 0.52% | Not reported | Q4 2014 | |
| $1.12M | 1.76% | 0.00% | -46.5% | Q2 2013 | |
| $1.03M | 1.62% | 0.36% | -11.6% | Q4 2019 | |
| $1.01M | 1.59% | 0.70% | -9.1% | Q3 2024 | |
| $1.01M | 1.58% | 0.00% | -36.7% | Q3 2017 | |
| $946K | 1.49% | 0.02% | -54.0% | Q2 2013 | |
| $909K | 1.43% | 0.18% | -10.4% | Q1 2021 | |
| $659K | 1.03% | 0.00% | -36.4% | Q2 2013 | |
| $576K | 0.90% | 0.00% | -51.9% | Q4 2024 | |
| $462K | 0.73% | 0.03% | Not reported | Q4 2021 | |
| $458K | 0.72% | Not reported | New | Q1 2025 | |
| $428K | 0.67% | 0.05% | -13.6% | Q1 2023 | |
| $416K | 0.65% | 0.01% | -15.5% | Q3 2024 | |
| $400K | 0.63% | 0.05% | Not reported | Q2 2021 | |
| $360K | 0.57% | Not reported | Not reported | Q1 2024 | |
| AMAVNSAvanos Medical, Inc. | $318K | 0.50% | 0.05% | Not reported | Q4 2019 |
| $312K | 0.49% | 0.06% | -52.1% | Q1 2024 | |
| $305K | 0.48% | 0.11% | -28.4% | Q4 2019 | |
| $289K | 0.45% | 0.00% | -50.4% | Q3 2020 | |
| $267K | 0.42% | 0.00% | -17.2% | Q3 2024 | |
| $245K | 0.39% | 0.04% | -5.2% | Q4 2020 | |
| $244K | 0.38% | 0.05% | Not reported | Q2 2013 | |
| $232K | 0.36% | 0.00% | Not reported | Q3 2024 | |
| $225K | 0.35% | 0.00% | -11.8% | Q3 2024 | |
| $210K | 0.33% | 0.00% | Not reported | Q3 2017 | |
| $202K | 0.32% | 0.00% | Not reported | Q3 2024 | |
| $201K | 0.32% | 0.00% | -14.3% | Q3 2024 | |
| $193K | 0.30% | 0.00% | Not reported | Q3 2024 | |
| Q4 2024Reported Feb 12, 202588 positions | |||||
| $7.32M | 8.55% | 5.41% | -32.3% | Q4 2020 | |
| $3.88M | 4.53% | 0.01% | Not reported | Q1 2022 | |
| $3.84M | 4.48% | 2.88% | -21.0% | Q2 2014 | |
| $3.75M | 4.38% | 0.42% | -24.1% | Q3 2021 | |
| $3.68M | 4.30% | 0.10% | +9.4% | Q3 2024 | |
| $3.67M | 4.29% | 0.13% | -20.9% | Q3 2024 | |
| $3.47M | 4.05% | Not reported | -39.2% | Q1 2022 | |
| $2.86M | 3.34% | 0.00% | -5.8% | Q1 2022 | |
| $2.8M | 3.27% | Not reported | -53.4% | Q4 2014 | |
| $2.48M | 2.90% | 0.08% | -57.0% | Q3 2016 | |
| $2.33M | 2.72% | 0.21% | -27.6% | Q2 2014 | |
| $2.27M | 2.65% | 0.49% | -63.5% | Q4 2016 | |
| $2.21M | 2.58% | 0.00% | Not reported | Q1 2023 | |
| $2.07M | 2.42% | 0.04% | -49.7% | Q2 2013 | |
| $2.01M | 2.35% | 0.01% | Not reported | Q1 2021 | |
| $1.95M | 2.28% | 0.06% | -45.6% | Q3 2020 | |
| $1.92M | 2.24% | 0.00% | Not reported | Q2 2013 | |
| $1.88M | 2.20% | 0.08% | -23.4% | Q2 2022 | |
| $1.86M | 2.18% | 0.04% | -38.5% | Q3 2017 | |
| $1.78M | 2.08% | Not reported | Not reported | Q1 2020 | |
| $1.75M | 2.04% | 0.22% | -52.9% | Q2 2021 | |
| $1.63M | 1.91% | 0.91% | -12.9% | Q2 2022 | |
| CPTBRGComputer Programs & Systems Inc | $1.61M | 1.87% | Not reported | -55.0% | Q1 2024 |
| $1.6M | 1.87% | Not reported | -33.4% | Q1 2018 | |
| $1.56M | 1.82% | 0.00% | Not reported | Q3 2017 | |
| $1.34M | 1.57% | 0.78% | +182.4% | Q3 2024 | |
| $1.29M | 1.50% | 0.41% | -54.1% | Q4 2019 | |
| $1.26M | 1.47% | 0.02% | Not reported | Q3 2015 | |
| $1.16M | 1.35% | 0.20% | -66.9% | Q1 2021 | |
| $1.16M | 1.35% | 0.04% | -47.6% | Q1 2024 | |
| $1.05M | 1.23% | 0.00% | New | Q4 2024 | |
| $1.04M | 1.21% | 0.00% | +55.8% | Q2 2013 | |
| $677K | 0.79% | 0.01% | -45.9% | Q3 2020 | |
| $664K | 0.77% | 0.01% | -52.0% | Q3 2024 | |
| $629K | 0.73% | 0.12% | -79.2% | Q1 2024 | |
| $559K | 0.65% | 0.37% | -72.4% | Q2 2023 | |
| $504K | 0.59% | 0.07% | Not reported | Q1 2023 | |
| LLGTYLogility Inc | $475K | 0.55% | Not reported | -73.8% | Q1 2024 |
| $464K | 0.54% | 0.16% | -68.5% | Q4 2019 | |
| SSCWXSecureWorks Corp. | $369K | 0.43% | Not reported | -82.1% | Q4 2020 |
| $363K | 0.42% | 0.00% | Not reported | Q3 2024 | |
| $353K | 0.41% | 0.02% | Not reported | Q4 2019 | |
| $352K | 0.41% | Not reported | Not reported | Q1 2024 | |
| $325K | 0.38% | 0.00% | Not reported | Q3 2024 | |
| $287K | 0.33% | 0.00% | Not reported | Q3 2024 | |
| $284K | 0.33% | 0.00% | Not reported | Q3 2024 | |
| $264K | 0.31% | 0.04% | Not reported | Q4 2020 | |
| $233K | 0.27% | 0.00% | Not reported | Q3 2024 | |
| $213K | 0.25% | 0.05% | Not reported | Q2 2013 | |
| $178K | 0.21% | 0.00% | Not reported | Q3 2017 | |
Premium opens every quarter this fund has filed